Spots Global Cancer Trial Database for hycamtin
Every month we try and update this database with for hycamtin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Topotecan and Gefitinib (Iressa) for Ovarian, Peritoneal, or Fallopian Tube Cancer | NCT00317772 | Ovarian Cancer Peritoneal Neop... Fallopian Tube ... | Topotecan Gefitinib | - | M.D. Anderson Cancer Center | |
| Study of Temsirolimus, Topotecan, and Bortezomib | NCT00770731 | Advanced Cancer | Torisel (Temsir... Hycamtin (Topot... Velcade (Bortez... | - | M.D. Anderson Cancer Center | |
| Topotecan, Ifosfamide and Carboplatin in Children and Young Adults With Solid Tumors | NCT00502892 | Solid Tumors | Topotecan Ifosfamide Carboplatin | - 45 Years | M.D. Anderson Cancer Center | |
| Topotecan and Gefitinib (Iressa) for Ovarian, Peritoneal, or Fallopian Tube Cancer | NCT00317772 | Ovarian Cancer Peritoneal Neop... Fallopian Tube ... | Topotecan Gefitinib | - | M.D. Anderson Cancer Center | |
| A Bioequivalence Study of Two Oral Formulations of Topotecan in Patients With Advanced Solid Tumors | NCT00046111 | Lung Cancer, Sm... Solid Tumor Can... | topotecan | 18 Years - | GlaxoSmithKline | |
| SCOT Registry: Small Cell Lung Cancer Treatment and Outcome | NCT00997061 | Lung Cancer, Sm... | HYCAMTIN | 18 Years - | GlaxoSmithKline | |
| Ph I Oral Topotecan and Temozolomide for Patients With Malignant Gliomas | NCT00610571 | Glioblastoma Gliosarcoma Anaplastic Astr... | Oral Topotecan ... | 18 Years - | Duke University | |
| Oral Topotecan Versus Intravenous Docetaxel In Pretreated, Advanced Non-Small Cell Lung Cancer | NCT00049998 | Non-Small-Cell ... | topotecan | 18 Years - | GlaxoSmithKline | |
| Ph I Oral Topotecan and Temozolomide for Patients With Malignant Gliomas | NCT00610571 | Glioblastoma Gliosarcoma Anaplastic Astr... | Oral Topotecan ... | 18 Years - | Duke University | |
| Phase II Study of Pazopanib and Topotecan in Cervical Cancer | NCT02348398 | Cervical Cancer | Pazopanib Topotecan Phone Call | 18 Years - | M.D. Anderson Cancer Center | |
| Topotecan Vs. Topotecan + Etoposide Vs.Topotecan + Gemcitabine in Ovarian Cancer Therapy | NCT00312988 | Ovarian Cancer | Hycamtin Gemcitabine | 18 Years - | North Eastern German Society of Gynaecological Oncology | |
| TMC (Topotecan, Cyclophosphamide and Melphalan) for Multiple Myeloma | NCT01039025 | Myeloma | Topotecan Cyclophosphamid... Melphalan Peripheral Bloo... | - 70 Years | M.D. Anderson Cancer Center | |
| Topotecan, Ifosfamide and Carboplatin in Children and Young Adults With Solid Tumors | NCT00502892 | Solid Tumors | Topotecan Ifosfamide Carboplatin | - 45 Years | M.D. Anderson Cancer Center | |
| Second-Line Therapy Study For Potentially Platinum-Sensitive Relapsed Ovarian Cancer | NCT00316173 | Ovarian Cancer Neoplasms, Ovar... | topotecan CARBOPLATIN | 18 Years - | GlaxoSmithKline | |
| Therapy With Topotecan and Carboplatin by Patients With Relapsed Ovarian Cancer | NCT00170625 | Ovarian Cancer | Hycamtin | 18 Years - | North Eastern German Society of Gynaecological Oncology | |
| Brain Metastases In ErbB2-Positive Breast Cancer | NCT00437073 | Neoplasms, Brea... | capecitabine topotecan lapatinib | 18 Years - | GlaxoSmithKline | |
| Intravenous Weekly Topotecan In Subjects With Recurrent Or Persistent Endometrial Cancer | NCT00267488 | Neoplasms, Endo... Endometrial Can... | topotecan | 18 Years - | GlaxoSmithKline | |
| Topotecan and Gefitinib (Iressa) for Ovarian, Peritoneal, or Fallopian Tube Cancer | NCT00317772 | Ovarian Cancer Peritoneal Neop... Fallopian Tube ... | Topotecan Gefitinib | - | M.D. Anderson Cancer Center | |
| The Study Of An Oral Drug Called A Radiation Sensitizer In Patients With Newly Diagnosed Small Cell Lung Cancer (SCLC) | NCT00043862 | Lung Cancer, Sm... Small Cell Lung... | topotecan | 18 Years - | GlaxoSmithKline | |
| LCL161 Plus Topotecan for Patients With Relapsed/Refractory Small Cell Lung Cancer and Select Gynecologic Malignancies | NCT02649673 | Small Cell Lung... Ovarian Cancer | LCL161 Topotecan Pegylated GCSF ... | 18 Years - | SCRI Development Innovations, LLC |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
